Recent Updates
Recently added Catalysts
PRTA

Prothena to Participate in the Jefferies Healthcare Conference

Thursday, May 30, 2019 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: DUBLIN, Ireland, May 30, 2019 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage neuroscience company, today announced that members of its senior management team will present and participate in the Jefferies Healthcare Conference on June 6th at 10:30 AM

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
8.1%
average across 2 past catalysts
Cash runway
~34 mo
Minimal dilution risk
Lead asset
PRX003
Phase 1 · Psoriasis

Full Press Release Details

DUBLIN, Ireland, May 30, 2019 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage neuroscience company, today announced that members of its senior management team will present and participate in the Jefferies Healthcare Conference on June 6th at 10:30 AM ET in New York, NY.
A live webcast of the presentation can be accessed through the Investors section of the Company's website at www.prothena.com. Following the live presentation, a replay of the webcast will be available on the Company's website for at least 90 days following the presentation date.
Media & Investor Contact:
ShareAdd on Google
Tags: PRTA Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: May 30, 2019

Biotech snapshot

Cash runway
$288M liquidity · $8M/mo burn
~34 mo
Minimal dilution risk
Lead asset
PRX003Phase 1
Psoriasis →

Catalyst track record

+34%
best trade around PRTA's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for PRTA.

See every catalyst's timing & PoA →